Indian Journal of Nuclear Medicine

CASE REPORT
Year
: 2018  |  Volume : 33  |  Issue : 1  |  Page : 55--56

Trails on 18F-Fluorodeoxyglucose positron emission tomography/computed tomography leading to diagnosis of testicular adrenal rest tumor


Raghava Kashyap 
 Department of Nuclear Medicine and PET, Mahatma Gandhi Cancer Hospital and Research Institute, Visakhapatnam, Andhra Pradesh, India

Correspondence Address:
Dr. Raghava Kashyap
Department of Nuclear Medicine and PET, Mahatma Gandhi Cancer Hospital and Research Institute, MVP Colony, Visakhapatnam, Andhra Pradesh
India

Abstract

Testicular adrenal rest tumors (TARTs) are secondary to hypertrophy of adrenal rest cells in the rete testis in settings of hypersecretion of androgens. We present a case of congenital adrenal hyperplasia with TART with clues to the diagnosis on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). To the best of our knowledge, this is the first reported case on the role of 18F-FDG PET/CT in TART.



How to cite this article:
Kashyap R. Trails on 18F-Fluorodeoxyglucose positron emission tomography/computed tomography leading to diagnosis of testicular adrenal rest tumor.Indian J Nucl Med 2018;33:55-56


How to cite this URL:
Kashyap R. Trails on 18F-Fluorodeoxyglucose positron emission tomography/computed tomography leading to diagnosis of testicular adrenal rest tumor. Indian J Nucl Med [serial online] 2018 [cited 2021 Apr 18 ];33:55-56
Available from: https://www.ijnm.in/text.asp?2018/33/1/55/223238


Full Text



 Introduction



Interpretation of 18F-FDG PET has pitfalls from areas of benign physiological and pathological uptake of glucose. However, the same areas of physiological uptake can be secondary changes that, many a time, yield clues to underlying disease process. We present one such case where the FDG distribution yielded clue to disease process which was not known prior to the PET scan and thereby significantly altering the course of the management of the patient.

 Case Report



A 17-year-old male was diagnosed with bilateral testicular mass lesions. The right orchidectomy was done, and histology was interpreted as Leydig cell tumor. The patient was referred for restaging with an 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT). The whole-body image shows increased uptake in the left scrotum [Figure 1]a. Incidentally, there was unusual and prominent increased uptake in the adrenal glands on both sides [Figure 1]a. The corresponding CT images showed a significant hypertrophy of the adrenal glands [Figure 1]b with increased metabolism [Figure 1]c. The lesion in the left testis showed homogeneous enhancement measuring 1.5 cm × 2.6 cm with irregular margin and standardized uptake value (SUVmax) of 4 [Figure 2]a and [Figure 2]b. Review of clinical history revealed short stature height of 147 cm and early onset of pubic hair at 8 years age. The patient also demonstrated orthostatic hypotension with systolic blood pressure in the recumbent position being 130 mmHg, and on standing, it was 100 mmHg. The 17-hydroxyprogesterone levels were elevated on subsequent evaluation (>20 ng/ml). The presence of bilateral testicular lesions, with adrenal hypertrophy, features of androgen excess in the form of early pubarche, short stature, and biochemical evidence of raised 17-OH progesterone leads conclusively to diagnosis of congenital adrenal hyperplasia (CAH) with testicular adrenal rest tumor (TART). The patient was referred to an endocrinologist for semen analysis and further management.{Figure 1}{Figure 2}

 Discussion



TARTs are benign tumors. They are associated with CAH. Up to 94% of patients with CAH can have TARTs.[1] They are typically present in rete testis and commonly bilateral. Usually, CAH is due to congenital defect in the 21-hydroxylase enzyme which results in aldosterone deficiency. This activates the feedback and resulting in increased pituitary secretion of Adrenocorticotropic hormone that results in adrenal hypertrophy and overproduction of adrenal androgens.

When large, these tumors result in obstructive azoospermia and infertility. TARTs are often misdiagnosed as Leydig cell tumors due to similar features on pathology resulting in a diagnostic dilemma.[2] The presence of tumors bilaterally and biochemical features can aid in appropriate diagnosis. Leydig cell tumor tends to show relatively higher metabolic activity [3] while the left testicular lesion in our study showed mildly increased uptake compared to the liver (SUVmax 4).

In patients with TARTs, glucocorticoid suppression can result in regression of the growth. The patient should be evaluated for infertility, and orchidectomy is reserved until irreversible changes are noticed in the testis secondary to obstruction from the tumor. Testis-sparing surgery is also considered in these patients.[4] Rich et al.[5] advocate an “aggressive conservative approach” in children diagnosed with Leydig cell tumors and that orchidectomy should not be attempted without complete endocrine profile in these patients.

In our case, the presence of abnormal hypertrophied adrenal glands in the whole-body image showing hypermetabolism was the clue that leads to re-examination of the entire clinical history and changing the diagnosis of the patient and changing the treatment plan. To the best of our knowledge, this is the first reported case on the role of 18 F-FDG PET/CT in TART.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Claahsen-van der Grinten HL, Otten BJ, Stikkelbroeck MM, Sweep FC, Hermus AR. Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 2009;23:209-20.
2Ali HH, Samkari A, Arabi H. Testicular adrenal rest “tumor” or Leydig cell tumor? A report of a challenging case with literature review. Avicenna J Med 2013;3:15-9.
3Lee G, Lee JH, Lee WA. F-18 FDG PET/CT imaging of a Leydig cell tumor. Clin Nucl Med 2010;35:202-4.
4Walker BR, Skoog SJ, Winslow BH, Canning DA, Tank ES. Testis sparing surgery for steroid unresponsive testicular tumors of the adrenogenital syndrome. J Urol 1997;157:1460-3.
5Rich MA, Keating MA, Levin HS, Kay R. Tumors of the adrenogenital syndrome: An aggressive conservative approach. J Urol 1998;160:1838-41.